STING1 and cancer: Nanobody engineered OMVs loaded with IR700 systemically induce STING signaling in cancer cells and TAMs to enhance antitumor innate immunity and synergistically improve the efficacy of immune checkpoint blockades, potentially triggering sustained antitumor memory.